NDC codes

414365 NDC codes with hospital pricing data in the network.

• NDC 83490-0207-60 — 7% sodium chloride solution for nebulizationAI (141 hospitals, 54,826–55,735 samples)
• NDC 63323-0367-01 — Polymyxin B antibiotic injection, 500,000 unitsAI (85 hospitals, 54,824–55,724 samples)
• NDC 00990-7974-08 — Glycine 1.5% urologic irrigation solutionAI (100 hospitals, 54,772–55,708 samples)
• NDC 50190-0740-60 — Sodium chloride 7% nebulizer solutionAI (163 hospitals, 54,772–55,708 samples)
• NDC 76204-0022-60 — 3% sodium chloride nebulizer solutionAI (521 hospitals, 54,751–55,687 samples)
• NDC 00409-1752-50 — Marcaine with epinephrine 0.25% injectionAI (544 hospitals, 54,621–55,656 samples)
• NDC 44567-0642-10 — Norepinephrine IV drip in salineAI (209 hospitals, 54,452–55,649 samples)
• NDC 00338-0519-13 — Soybean oil intravenous fat emulsionAI (263 hospitals, 54,747–55,647 samples)
• NDC 67457-0001-00 — Ketamine 50 mg/mL injectionAI (215 hospitals, 54,747–55,647 samples)
• NDC 00338-0519-58 — Intravenous fat emulsion 20%AI (248 hospitals, 54,747–55,647 samples)
• NDC 25021-0668-05 — Cisatracurium injection, 10 mg per 5 mLAI (97 hospitals, 54,747–55,647 samples)
• NDC 00338-0289-47 — Glycine 1.5% urologic irrigation solutionAI (208 hospitals, 54,747–55,647 samples)
• NDC 00409-5779-01 — Intravenous electrolyte solution with sodium, potassium, magnesium, calciumAI (164 hospitals, 54,747–55,647 samples)
• NDC 00990-7967-09 — Balanced electrolyte IV fluid (pH 7.4)AI (162 hospitals, 54,747–55,647 samples)
• NDC 47335-0615-40 — Norepinephrine 1 mg/mL intravenous solutionAI (120 hospitals, 54,747–55,647 samples)
• NDC 70860-0652-20 — ETOMIDATE 2 MG/ML INTRAVENOUS SOLUTIONAI (59 hospitals, 54,747–55,647 samples)
• NDC 00409-5779-11 — Intravenous multi-electrolyte replacement solutionAI (92 hospitals, 54,747–55,647 samples)
• NDC 17478-0415-01 — Ephedrine sulfate 50 mg/mL injection solutionAI (148 hospitals, 54,747–55,647 samples)
• NDC 72611-0756-01 — Rocuronium bromide injection, 50 mg per 5 mLAI (149 hospitals, 54,747–55,647 samples)
• NDC 54643-7886-01 — Pediatric multivitamin with vitamin K injectionAI (58 hospitals, 54,747–55,647 samples)
• NDC 44567-0642-01 — Norepinephrine IV drip in salineAI (227 hospitals, 53,864–55,619 samples)
• NDC 72266-0234-01 — Ketorolac 15 mg/mL injectionAI (301 hospitals, 53,808–55,608 samples)
• NDC 65219-0054-29 — Potassium phosphate IV solutionAI (352 hospitals, 54,609–55,590 samples)
• NDC 00264-1933-10 — Trophamine 10% intravenous solutionAI (404 hospitals, 54,437–55,562 samples)
• NDC 63323-0492-26 — Xylocaine (lidocaine) 1% injection solutionAI (272 hospitals, 52,474–55,561 samples)
• NDC 69784-0231-20 — Sodium acetate intravenous solutionAI (187 hospitals, 54,587–55,487 samples)
• NDC 00781-3493-95 — Dexmedetomidine IV infusion in sodium chlorideAI (220 hospitals, 54,488–55,478 samples)
• NDC 00093-6816-55 — Budesonide inhalation suspension 0.5 mg per 2 mLAI (319 hospitals, 54,423–55,395 samples)
• NDC 72485-0108-25 — VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTIONAI (215 hospitals, 54,455–55,391 samples)
• NDC 69784-0230-10 — Sodium acetate intravenous solutionAI (190 hospitals, 54,569–55,388 samples)
• NDC 00069-0315-01 — Bevacizumab-bvzr intravenous solutionAI (694 hospitals, 55,007–55,385 samples)
• NDC 63323-0806-02 — Fentanyl citrate injection, 100 mcg per 2 mLAI (501 hospitals, 40,006–55,369 samples)
• NDC 70756-0611-25 — Ephedrine sulfate 50 mg/mL injectionAI (270 hospitals, 54,340–55,366 samples)
• NDC 60793-0215-05 — Thrombin topical solution, 5,000 unitsAI (1041 hospitals, 54,276–55,356 samples)
• NDC 00517-2502-01 — Caffeine and sodium benzoate injectionAI (366 hospitals, 54,132–55,356 samples)
• NDC 43066-0031-25 — VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTIONAI (170 hospitals, 54,338–55,346 samples)
• NDC 63323-0492-08 — Lidocaine (1%) numbing injectionAI (185 hospitals, 52,304–55,346 samples)
• NDC 00143-9232-10 — Vecuronium bromide 20 mg injectionAI (63 hospitals, 54,412–55,285 samples)
• NDC 00409-1103-01 — Cisatracurium injection (paralyzing medication for surgery)AI (236 hospitals, 54,043–55,267 samples)
• NDC 63323-0418-20 — Cisatracurium injection, 200 mg vialAI (441 hospitals, 54,112–55,264 samples)
• NDC 70860-0103-10 — Polymyxin B injection, 500,000-unit vialAI (200 hospitals, 54,288–55,242 samples)
• NDC 70092-1148-43 — Sodium citrate 4% syringeAI (291 hospitals, 54,353–55,226 samples)
• NDC 00409-4090-11 — Zinc trace element intravenous solutionAI (176 hospitals, 54,424–55,225 samples)
• NDC 00409-4090-01 — Zinc chloride injectionAI (320 hospitals, 54,349–55,204 samples)
• NDC 55150-0297-10 — Dexmedetomidine IV infusion in salineAI (297 hospitals, 54,069–55,194 samples)
• NDC 70710-1643-01 — Verapamil hydrochloride injection 2.5 mg/mLAI (291 hospitals, 54,041–55,184 samples)
• NDC 60793-0217-20 — Thrombin topical solution, 20,000 unitsAI (510 hospitals, 54,009–55,062 samples)
• NDC 50419-0325-37 — Gadobutrol contrast injection, 2 mL vialAI (354 hospitals, 51,052–55,048 samples)
• NDC 00378-6993-93 — Levalbuterol 1.25 mg/0.5 mL inhalation nebulizer solutionAI (328 hospitals, 53,923–55,039 samples)
• NDC 00409-8183-11 — Potassium acetate injectionAI (342 hospitals, 54,135–55,017 samples)